| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 37 | IT 3 | 99.27 |
| Neuroendocrine Tumor Research Advances | Lifetime | 242 | IT 28 | 98.98 |
| Dermatological and Skeletal Disorders | Lifetime | 48 | IT 3 | 98.55 |
| Peptidase Inhibition and Analysis | Lifetime | 390 | IT 14 | 98.50 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 153 | IT 23 | 98.70 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 163 | IT 13 | 98.33 |
| Parathyroid Disorders and Treatments | Lifetime | 190 | IT 12 | 98.67 |
| Multiple Myeloma Research and Treatments | Lifetime | 296 | IT 24 | 98.24 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 331 | IT 8 | 97.69 |
| Drug Transport and Resistance Mechanisms | Lifetime | 857 | IT 17 | 96.84 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 641 | IT 65 | 97.26 |
| Eosinophilic Disorders and Syndromes | Lifetime | 531 | IT 48 | 96.29 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 790 | IT 48 | 82.15 |
| Planarian Biology and Electrostimulation | Lifetime | 790 | IT 34 | 74.51 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 26 | IT 8 | 98.86 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 109 | IT 13 | 97.98 |
| Parathyroid Disorders and Treatments | 2021-2025 | 87 | IT 18 | 96.23 |
| Dermatological and Skeletal Disorders | 2021-2025 | 24 | IT 4 | 91.58 |
| Peptidase Inhibition and Analysis | 2021-2025 | 329 | IT 20 | 93.48 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 124 | IT 13 | 93.70 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 359 | IT 71 | 92.97 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 723 | IT 64 | 93.10 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 348 | IT 38 | 92.15 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 884 | IT 53 | 88.68 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 420 | IT 17 | 83.47 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 826 | IT 69 | 72.62 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 679 | IT 26 | 46.56 |